查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190480

顱骨固定和穩定係統市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Cranial Fixation and Stabilization Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 132 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

顱骨固定和穩定係統市場預計在預測期內（2022 年至 2027 年）的複合年增長率為 8.7%。

COVID-19 爆發是前所未有的健康問題，對顱骨固定和穩定係統市場產生了重大影響。 由於 SARS-CoV-2 感染與神經和神經精神疾病相關，這種流行病仍處於新變種擴張的初期階段，因此患有長期神經病的患者會受到嚴重影響。 因此，神經外科手術在 COVID-19 期間被推遲或延遲，對早期研究的市場產生了不利影響。 例如，根據 2021 年 11 月發表在 Acta Neurochirurgica 上的題為“神經外科和冠狀病毒：影響和挑戰——從第一波全球大流行中汲取的教訓”的研究，大流行期間急診神經外科轉診率為 33.6%。下降了 55.6 個百分點。 因此，患者對顱骨固定和穩定係統的需求正在減少。

顱骨固定是一種旨在確保開顱手術後更換的顱骨瓣結構穩定性的過程。 這是醫學上最精細和最苛刻的程序。 在此過程中，將骨瓣、碎片或移植物固定到顱骨上以實現穩定閉合。 根據世界衛生組織的數據，2021 年 10 月，約有 130 萬人死於道路交通事故，另有 20-30 萬人傷殘。 有 20 至 5000 萬人遭受非致命傷害，其中許多人因傷致殘。 這種傷害可能會增加對顱骨固定術的需求，因為顱骨內關鍵結構的固定提供了更高的精度。

此外，監管部門的批准也在推動市場增長。 例如，2021 年 10 月，OssDsign 的患者專用顱骨植入物 OssDsign Cranial PSI 獲得了美國食品和藥物管理局 (FDA) 的擴大市場批准。

神經系統疾病患病率上升、交通事故和傷害發生率上升以及顱骨固定和穩定係統領域的技術進步是顱骨固定和穩定係統市場增長的主要驅動力。 然而，高昂的手術費用可能會阻礙市場增長。

顱骨固定和穩定係統的市場趨勢

預計在預測期內顱骨固定係統部分將佔據主要市場份額

顱骨固定係統專為顱骨的結構穩定性而設計，用於神經外科和脊柱外科手術。 推動該行業增長的主要因素是交通事故的增加、技術進步導致的神經系統疾病激增以及研發活動的增加。

根據世界衛生組織（WHO）公佈的數據，2021年全球每年將有超過135萬人死於交通事故，5000萬人受傷。 交通事故和傷害的增加不僅會影響個人的身體，還會影響導致開顱手術的顱骨，從而推動患者群體對顱骨固定係統的需求。

此外，定制產品的提供和需要顱骨固定係統的腦外科手術的增加也有望推動這一細分市場的增長。 例如，根據一項題為“A new device for bone cranial flap fixation”的研究，“A new device for bone cranial flap fixation: Technical note and surgical remarks.A multicentric experience”於 2021 年 2 月由 Surgical Neurology International Cranial Fixation 發表是一種安全、可靠且易於使用的術後顱骨瓣固定係統。 開顱術後骨瓣固定在任何神經外科手術中都起著重要作用。 因此，在神經手術中越來越多地使用顱骨系統可能會對這一領域的增長產生積極影響。

因此，事故和腦損傷發生率的上升以及神經系統疾病患病率的增加是顱骨固定係統細分市場增長的主要驅動因素。

北美將佔據很大的市場份額，預計在預測期內也會如此

由於事故和腦損傷的發生率不斷上升，以及神經系統疾病的患病率不斷上升，預計北美將在全球顱骨固定和穩定係統市場中佔有重要的市場份額。

此外，由於神經系統疾病的高發率和新產品的推出，市場預計會增長。 例如，根據 2020 年 11 月發布的《加拿大腦損傷統計》，加拿大每年 10 萬人中有 500 人發生創傷性腦損傷。 這意味著加拿大每天有近 456 人受傷，或每三分鐘就有一人受傷。 如此高的腦損傷負擔預計會增加對顱骨固定和穩定係統的需求，進而推動該地區的市場增長。

此外，該地區的人口正在老齡化，隨著老年人更容易患上神經退行性疾□□病，神經系統疾病的負擔預計會增加。 例如，根據加拿大統計局 2022 年 4 月發表的一篇題為“2021 年人口普查中 85 歲及以上的加拿大人口增長情況”的文章，2021 年人口普查中 85 歲及以上的人口超過 861,000。 另據報導，85歲以上人口占加拿大總人口的2.3%。 此外，顱骨固定和穩定係統的技術進步以及不斷上升的醫療成本水平也在推動區域市場的增長。

因此，上述因素有望刺激北美市場的增長。

顱骨固定和穩定係統市場競爭分析

顱骨固定裝置和穩定係統市場分散且競爭激烈，由幾家大型企業組成。 從市場份額的角度來看，一些主要參與者主導著市場。 一些大公司通過擴張、合同、新產品發布、合資企業、收購和合作夥伴關係等各種戰略擴大了他們在這個市場的足跡。 目前主導市場的公司包括 Integra LifeSciences Corporation、B. Braun Melsungen AG、Depuy Synthes (Johnson & Johnson)、Medtronic Plc、Stryker Corporation、Zimmer Biomet Holding, Inc、Evonos GmbH & Co.KG、Changzhou Huida Medical Instrument、Jeil Medical公司和 KLS 馬丁集團。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 神經系統疾病的患病率增加
    • 道路交通事故和受傷率增加
    • 顱骨固定和穩定係統領域的技術進步
  • 市場製約因素
    • 手術費用上漲
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品類型
    • 顱骨固定係統
    • 顱骨固定係統
  • 按材料類型
    • 可吸收固定係統
    • 不可吸收固定係統
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Integra LifeSciences Corporation
    • B. Braun Melsungen AG
    • Depuy Synthes（Johnson & Johnson）
    • Medtronic Plc
    • Stryker Corporation
    • Zimmer Biomet Holding, Inc
    • Evonos GmbH & Co. KG
    • Changzhou Huida Medical Instrument Co., Ltd
    • Jeil Medical Corporation
    • KLS Martin Group
    • NEOS Surgery
    • Medicon
    • OsteoMed

第7章 市場機會今後動向

簡介目錄
Product Code: 67833

The Cranial Fixation and Stabilization Systems Market is expected to register a CAGR of 8.7% during the forecast period (2022-2027).

The COVID-19 outbreak was an unprecedented health concern and has significantly impacted the cranial fixation and stabilization systems market. With the pandemic still in its expansion phase with newer variants, patients with long-term neurological disorders are severely impacted as the SARS-CoV-2 infection worsened when it was associated with neurological and neuropsychiatric illness. Thus, neurological surgeries were delayed or postponed during COVID-19, adversely impacting the market studied in its initial phase. For instance, according to the study titled "Neurosurgery and coronavirus: impact and challenges-lessons learned from the first wave of a global pandemic" published in the Acta Neurochirurgica in November 2021, amid the pandemic, there was a 33.6 percent decrease in neurosurgical emergency referrals and a 55.6 percent decrease in operations. Thus, decreasing the demand for cranial fixation and stabilization systems among the patient population.

Cranial fixation is the process designed to assure the structural stability of the replaced skull flap following a craniotomy procedure. It is the most delicate and demanding procedure in the field of medicine. In this procedure, bone flaps, fragments, or grafts are fixed to the cranium to provide stable closure. According to the World Health Organization, in October 2021, approximately 1.3 million people died in road accidents, and an additional 20-30 million were disabled or injured. Between 20 and 50 million people suffer from non-fatal injuries, with many incurring disabilities due to their injuries. Such injuries may result in an increased demand for cranial fixation procedures since these devices offer greater precision by immobilizing the main structures within the skull.

Additionally, the approval from the regulatory authorities is also propelling the growth of the market. For instance, in October 2021, OssDsign received expanded market clearance from United States Food and Drug Administration (FDA) for OssDsign Cranial PSI, a patient-specific cranial implant.

The increasing prevalence of neurological diseases, the rising incidence of road accidents and injuries, and technological advancements in the field of cranial fixation and stabilization systems are the key driving factors in the cranial fixation and stabilization systems market. However, the high cost of surgeries may impede the growth of the market.

Cranial Fixation & Stabilization Systems Market Trends

Cranial Fixation Systems Segment is Expected to Hold a Major Market Share Over the Forecast

A cranial fixation system is designed for structural stability of the skull and is used during neuro or spinal surgeries. The major factors driving the segment's growth are the growing number of road accidents; surge in the prevalence of neurological disorders coupled with technological advancements; and upsurge in research and development activities.

According to the World Health Organization (WHO) 2021, road traffic injuries lead to more than 1.35 million deaths yearly and cause up to 50 million injuries globally. Such an increase in road accidents and injuries may affect the individual's body as well as the skull resulting in craniotomy surgeries, in turn, boosting the demand for cranial fixation systems among the patient population.

Furthermore, the growing availability of customized product offerings and the increasing volume of brain surgeries requiring cranial fixation systems are also expected to augment the segment's growth. For instance, according to the study titled "A new device for bone cranial flap fixation: Technical note and surgical remarks. A multicentric experience" published in the Surgical Neurology International in February 2021, cranial fixation is a postoperative cranial bone flap fixation system that is safe, reliable, and simple to use. Every neurosurgical procedure majorly involves the fixation of bone flaps after craniotomy. Thus, increasing the use of the cranial system in neurological procedures is likely to have a positive impact on the segment's growth.

Thus, the rising incidence of accidents, brain injuries, and the increasing prevalence of neurological diseases are the key driving factors for cranial fixation system segment growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global cranial fixation and stabilization systems market due to the rising incidence of accidents, brain injuries, and the increasing prevalence of neurological diseases in this region.

Furthermore, due to the high prevalence of neurological diseases and new product launches, the market is expected to project growth. For instance, according to the Brain Injury Canada Statistics published in November 2020, in Canada, traumatic brain injury occurs at an annual rate of 500 out of 100,000 individuals. This means that nearly 456 people every day, or one person is injured every three minutes in Canada. Such a high burden of brain injuries is expected to boost the demand for cranial fixation and stabilization systems, in turn, driving the growth of the market in the region.

Also, the growing aging population in the region is expected to increase the burden of neurological diseases as the senior population is more prone to neurodegenerative disorders. For instance, according to the Statistics Canada article titled "A portrait of Canada's growing population aged 85 and older from the 2021 Census" published in April 2022, there are over 861,000 people aged 85 and older who were counted in the 2021 Census. It also reported that the population aged 85 and older comprise 2.3% of the total population of Canada. Furthermore, technological advancements in cranial fixation and stabilization systems and growing healthcare expenditure levels are also fueling the growth of the regional market to a large extent.

Thus, these aforementioned factors are likely to impel the market's growth in North America.

Cranial Fixation & Stabilization Systems Market Competitive Analysis

The Cranial Fixation and Stabilization Systems market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some major players have used various strategies such as expansions, agreements, new product launches, joint ventures, acquisitions, and partnerships to increase their footprints in this market. Some of the companies which are currently dominating the market include Integra LifeSciences Corporation, B. Braun Melsungen AG, Depuy Synthes (Johnson & Johnson), Medtronic Plc, Stryker Corporation, Zimmer Biomet Holding, Inc, Evonos GmbH & Co. KG, Changzhou Huida Medical Instrument Co., Ltd, Jeil Medical Corporation, and KLS Martin Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Neurological Diseases
    • 4.2.2 Increasing Incidence of Road Accidents and Injuries
    • 4.2.3 Technological Advancements in the Field of Cranial Fixation and Stabilization Systems
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgeries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Cranial Fixation System
    • 5.1.2 Cranial Stabilization Systems
  • 5.2 By Material Type
    • 5.2.1 Resorbable Fixation Systems
    • 5.2.2 Nonresorbable Fixation Systems
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Integra LifeSciences Corporation
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Depuy Synthes (Johnson & Johnson)
    • 6.1.4 Medtronic Plc
    • 6.1.5 Stryker Corporation
    • 6.1.6 Zimmer Biomet Holding, Inc
    • 6.1.7 Evonos GmbH & Co. KG
    • 6.1.8 Changzhou Huida Medical Instrument Co., Ltd
    • 6.1.9 Jeil Medical Corporation
    • 6.1.10 KLS Martin Group
    • 6.1.11 NEOS Surgery
    • 6.1.12 Medicon
    • 6.1.13 OsteoMed

7 MARKET OPPORTUNITIES AND FUTURE TRENDS